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Objective To provide information on trends on official
development assistance (ODA) disbursement patterns for
reproductive health activities in 18 conflict-affected countries.
Design Secondary data analysis.
Sample 18 conflict-affected countries and 36 non-conflict-affected
countries.
Methods The Creditor Reporting System (CRS) database was
analyzed for ODA disbursement for direct and indirect
reproductive health activities to 18 conflict-affected countries
(2002–2011). A comparative analysis was also made with 36 non-
conflict-affected counties in the same ‘least-developed’ income
category. Multivariate regression analyses examined associations
between conflict status and reproductive health ODA and between
reproductive needs and ODA disbursements.
Main outcome measures Patterns of ODA disbursements
(constant U.S. dollars) for reproductive health activities.
Results The average annual ODA disbursed for reproductive
health to 18 conflict-affected countries from 2002 to 2011 was
US$ 1.93 per person per year. There was an increase of 298% in
ODA for reproductive health activities to the conflict-affected
countries between 2002 and 2011; 56% of this increase was due
to increases in HIV/AIDS funding. The average annual per capita
reproductive health ODA disbursed to least-developed non-
conflict-affected countries was 57% higher than to least-
developed conflict-affected countries. Regression analyses
confirmed disparities in ODA to and between conflict-affected
countries.
Conclusions Despite increases in ODA for reproductive health for
conflict-affected countries (albeit largely for HIV/AIDS activities),
considerable disparities remains.
Keywords Aid, conflict, ODA, reproductive health, war.
Tweetable abstract Study tracking 10 years of aid for reproductive
aid shows major disparities for conflict-affected countries.
Linked article This article is commented on by Nynke van den
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Introduction
Reproductive health problems remain a leading cause of
mortality and morbidity for women and girls of childbear-
ing age worldwide.1 Impoverished women, especially those
living in low- and middle-income countries, suffer dispro-
portionately from unintended pregnancies, maternal death
and disability, sexually transmitted infections (STIs) includ-
ing HIV, and other problems related to their reproductive
system and sexual behaviour.1
There is strong evidence of increased mortality and mor-
bidity caused by poor access to reproductive health care in
all resource-poor countries but these tend to be worse in
countries currently experiencing armed conflict or recover-
ing from it.2,3 It is estimated that 170 000 maternal deaths
occur yearly during humanitarian emergencies.4 The major-
ity of the top ten countries with the highest maternal mor-
tality ratios globally are experiencing or emerging from
conflict.5 Higher rates of maternal mortality are also
recorded in areas with recent conflict.6 In the Democratic
Republic of Congo, for example, the contrast between the
conflict-affected eastern part of the country and the rela-
tively peaceful western part of the country is stark, with
maternal mortality ratios of 1174 and 881 deaths per
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Sexual health
100 000 live births, respectively.7 In many low- and mid-
dle-income countries, including conflict-affected countries,
women of reproductive age are the main carers for children
and elderly relatives, and so mortality and morbidity asso-
ciated with poor reproductive health outcomes have pro-
found long-term consequences for families and
communities.8
Ensuring access to comprehensive health information
and services, including reproductive health, is endorsed by
United Nations Security Council Resolutions 1820, 1888,
1889, 1960 and 1325, which are aimed at protecting
women in conflict and post-conflict situations.9,10 These
important resolutions include targeting gender-based vio-
lence, which is often an intentional strategy of war as well
as a consequence of increasing impunity in conflict-affected
countries.11 Essential reproductive health services and activ-
ities agreed by key governmental, inter-governmental and
non-governmental agencies are contained in leading
humanitarian guidelines (summarised in Box 1).12–15
Investment in reproductive health is one of the most-effec-
tive ways to improve health outcomes, promote equitable
and sustainable development and help alleviate poverty
across generations.2,16,17 Most reproductive health interven-
tions, such as family-planning services, are extremely cost-
effective in improving health outcomes and preventing
maternal mortality and HIV.18,19 The disruption caused by
conflict and displacement reduces women’s and men’s access
to family planning services.3 Recent studies have shown that
the provision of comprehensive family planning services is
widely accepted among conflict-affected populations.20,21
Official development assistance (ODA) is a major source
of the global financial response for health in low- and mid-
dle-income countries, including those currently affected by
armed conflict and those which are defined as post-conflict
(see definitions in Box 1). Evidence has shown that ODA for
reproductive health activities, including family planning,
remains low globally.22 In a previous study we analysed
ODA disbursed for reproductive health activities in 18 con-
flict-affected countries between 2003 and 2006.23 Our find-
ings indicated that ODA was increasing for reproductive
health to conflict-affected countries but this was largely attri-
butable to increased funding for HIV/AIDS activities,
whereas ODA for other reproductive health services was very
limited. The findings also showed lower absolute reproduc-
tive health ODA per capita to conflict-affected countries
than comparable non-conflict-affected countries despite
generally higher levels of reproductive health needs. The
study was useful for informing subsequent donor policies on
reproductive health in conflict-affected countries.16,24–26
Further evidence of long-term trends in reproductive health
ODA distribution is useful in understanding how responsive
aid is to levels of reproductive health needs and to address
issues of donor accountability and transparency.27–29
The overall objective of this follow-up study is to pro-
vide information on longer-term trends on ODA dis-
bursement patterns for reproductive health activities in 18
conflict-affected countries. The specific objectives are1: to
measure the absolute and per capita amount of reproduc-
tive health ODA to conflict-affected countries;2 to com-
pare reproductive health ODA disbursements to conflict-
affected countries and non-conflict-affected countries;3 to
analyse disbursement patterns of ODA disbursement for
different reproductive health-related activities;4 to analyse
disbursement patterns of reproductive health ODA by
donors.
Box 1. Key definitions
Reproductive Health follows the definition given in the
International Conference on Population and Development in
1994.30 It refers to the constellation of methods, techniques,
and services that contribute to reproductive health and well-
being by preventing and solving reproductive health
problems.31 Reproductive activities for conflict-affected
populations such as refugees and internally displaced persons
include family planning, HIV/AIDS and sexually transmitted
diseases, maternal and newborn health, comprehensive
abortion care, and sexual and gender-based violence.12 Note:
the revised version of the Inter Agency Field Manual (2010)
includes the following components in reproductive health:
family planning, maternal and newborn health, comprehensive
abortion care, preventing and responding to consequences of
gender-based violence, STIs, HIV and adolescent reproductive
health.
Official development assistance (ODA) is defined as flows of
official financing administered with the promotion of the
economic development and welfare of developing countries as
the main objective, including humanitarian aid. ODA receipts
comprise disbursements by bilateral donors and multilateral
institutions.32
Humanitarian aid is assistance designed to save lives, alleviate
suffering, and maintain and protect human dignity during and
in the aftermath of emergencies and disasters. To be classified as
humanitarian, aid should be consistent with the humanitarian
principles of humanity, impartiality, neutrality and
independence.33
Conflict-affected countries include those that are currently
engaged in war or those that are defined as post-conflict
countries. Conflict-affected countries were selected as having
been in ‘war’ at a point in the period 2000–2009 based upon the
Uppsala University Conflict Database, with additional
information used from the World Bank.34,35 Conflict or War
refers to violent armed struggle between hostile groups; there are
over 1000 battle-related deaths in 1 year in our definition of
conflict.36 Post-conflict is highly difficult to conceptualise and
may refer to the period following a formal surrender, negotiated
end of hostilities, or peace talks.37 It is a period with increased
security and peace, although there may be violence and
insecurity in certain regions; political and economic reforms and
the influx of large-scale private investment and development aid.
Some countries are described as post-conflict for up to two
decades or more after the end of hostilities; however, this tends
to be very context-specific depending on the typology of conflict.
Post-conflict peace is typically fragile: nearly half of all civil wars
are due to post-conflict relapses. 38
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Data source
Aid data was extracted for 2002–2011 from the open-access
Creditor Reporting System (CRS) database, available at
http://stats.oecd.org/Index.aspx?datasetcode=CRS1. CRS is
maintained by the Development Assistance Committee
(DAC) of the Organisation of Economic Cooperation and
Development (OECD). CRS data was determined to be the
most comprehensive source of information on ODA for
health and has been widely used for research on tracking
aid across different health sectors to all developing coun-
tries, including those affected by conflict.39–46 CRS covers
an estimated 100% of aid disbursements from 2007,
around 90% since 2002.47 It ensures that there is little or
no double-counting; data are validated by a peer-review
process. Reporting is mandatory for donors that use stan-
dard criteria, allowing for comparability between donors
and over time.47,48 Other databases such as AidData offer
less standardised data than CRS, which uses the same data
collection procedure across all donor agencies and is there-
fore considered to be the best data source for studying
trends in ODA from the same set of donors over time.49
The 18 countries selected for the study were those which
met the definitions of conflict-affected and/or post-conflict
(Box 1) and were the same as those used in the first study
so as to ensure continuity of analysis and to study long-
term patterns of aid for reproductive health for these coun-
tries. The CRS includes ODA from 26 bilateral donors and
18 multilateral agencies including UN programmes and
funds, World Bank groups, regional banks, and global
health initiatives such as the Global Fund to fight AIDS,
Tuberculosis and Malaria (GFATM) and the US President’s
Emergency Plan for AIDS Relief (PEPFAR). All bilateral
and multilateral donors were included in this study, as
were all types of funding approaches. The CRS includes
humanitarian aid; longer-term developmental program-
matic or project funding; pooled funding such as common
humanitarian funds for recipient countries; Sector-Wide
Approaches (SWAps) and basic packages of health services;
and general budget support. Bilateral and multilateral aid
are recorded separately in the CRS to avoid double-count-
ing.
This study did not include data from the Financial
Tracking System (FTS) to avoid double-counting, as it does
not provide additional data to that already included in
CRS. We contacted a number of specialists on humanitar-
ian funding from CRS, FTS and Global Humanitarian
Assistance to verify that CRS analysis would cover all aid
to conflict-affected countries including non-earmarked
funding allocated by donor countries to recipient countries,
and contributions to the Central Emergency Respond Fund
(CERF), Common Humanitarian Fund (CHF) and Emer-
gency Response Fund (ERF). These emergency funds are
reported in CRS by the donor countries to the recipient
country and channelled through the United Nations Office
for the Coordinator of Humanitarian Affairs (UN OCHA),
which is specified as an aid channel flow.50
Analysis
The methodology of analysing CRS follows that used in
our previous study.23 CRS-labelled aid activities were
selected that contributed either directly or indirectly to
reproductive health (Box 2). In the analysis, 100% of ODA
disbursements for direct reproductive health activities were
included: population policy and administration manage-
ment; reproductive health care (includes reproductive
health promotion, prenatal/postnatal/delivery care, safe
motherhood, fertility treatment, abortion related care);
family planning; personnel development for population and
reproductive health; social mitigation of HIV/AIDS; and
STD control, including HIV/AIDS. For the indirect activi-
ties, proportions of ODA disbursements for the following
activities were allocated for inclusion in the analysis: educa-
tion; basic nutrition; general health; general budget sup-
port; humanitarian material relief assistance and services;
and reconstruction relief and rehabilitation (Box 2). This
follows the previously used approach.23,39,51,52 Donor con-
tributions include both earmarked and non-earmarked
grants (non-earmarked funding means that the multilateral
agency has freedom to decide how the money is used). All
estimates were based on 2009 constant US dollars, using
CRS deflator rates to adjust for changes in the exchange
rate and inflation in the currency in which the flow
occurred between the year of the flow and the base year.
All ODA data for each recipient country selected for the
study were downloaded from the CRS and analysed in
EXCEL and STATA databases. Each of the CRS-labelled aid
activities is accompanied in the CRS database by a numeric
‘purpose-code,’ which was used for the data analysis. The
absolute and per capita amounts of ODA (constant US$)
were analysed for each of the 18 recipient countries for
individual direct and indirect reproductive health activities
and for combined reproductive health.
A comparative analysis of the total reproductive health
ODA was also made with ODA disbursed to comparable
non-conflict-affected countries. Of the 18 conflict-affected
countries, only three countries were not in the OECD/DAC
category of least-developed countries: Colombia, Iraq and
Sri Lanka. We therefore compared the 15 conflict-affected
countries which were in the OECD/DAC category of
least-developed countries with the remaining 36
non-conflict-affected countries in the least-developed coun-
try category.53 The methods described above for descrip-
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tively analysing the data for conflict-affected countries were
used for the 36 non-conflict-affected countries. We also
examined the association between a country’s conflict sta-
tus and receiving RH ODA disbursement through a series
of multivariate linear regression analyses. The outcomes
related to mean 2002–2011 per capita US$ RH ODA. The
exposure of interest was a binary variable of ‘conflict-
affected’ (i.e. the 15 conflict-affected least-developed coun-
tries) compared with non-conflict-affected (i.e. the 36 non-
conflict-affected least-developed countries). We modelled
conflict status against mean per capita RH ODA received
per disbursement in five separate regression models using
the following dependent variables1: mean per capita overall
RH ODA;3 mean per capita direct RH ODA (see Box 2);3
mean per capita HIV/AIDS only ODA (purpose codes
13040 and 16064, see Box 2);4 mean per capita reproduc-
tive health care ODA (purpose code 13020, see Box 2);
and5 mean per capita family planning ODA (purpose code
13030, see Box 2). To adjust for the potential confounding
effect of variables related to health outcomes, economic sta-
tus and governance, we used a step-wise multivariate
regression model. First, we included the following indepen-
dent variables in our model: key reproductive health indi-
cators (HIV prevalence rate, maternal mortality, and total
fertility rate), key economic data (GDP per capita) and
governance (government effectiveness and control of
corruption) for each recipient country – see Supporting
Information Table S1 for these data and the sources. These
were all entered as categorical variables. Using backward
stepwise elimination, we eliminated variables that were not
Box 2. Creditor reporting system activities included in the analysis
Activities (purpose code) % Allocation Basis for allocation
Direct activities*
Population policy & administration
management (13010)
100 Estimates based on calculations by the Netherlands Interdisciplinary
Demographic Institute (NIDI) and developed in the OECD 54th meeting
of the Working Party on Statistics, June 2005***Reproductive health care (13020)** 100
Family planning (13030) 100
Personnel development for population &
reproductive health (13081)
100
Social mitigation of HIV/AIDS (16064) 100
STD control, including HIV/AIDS (13040) 100
Indirect activities
Primary education (11220) 10 Estimates based on calculations by NIDI and developed in the OECD
54th meeting of the Working Party on Statistics, June 2005***Basic skills for youth and education (11230) 10
Early childhood education (11240) 10
Secondary education (11320) 10
Health policy & administrative
management (12110)
10
Basic health care (12220) 25
Basic health infrastructure (12230) 25
Basic nutrition (12240) 75
Health education (12261) 25
Health personnel development (12281) 25
General budget support (51010) 2.11 Estimate based on average government expenditure on health for the
18 sampled countries (8.42%). **** 25% of this 8.42% was then
allocated for RH based on NIDI estimates.
Material relief assistance and services (72010) 1.94 Estimate based upon calculation of 7.76% of humanitarian ODA being
allocated to the health sector using Financial Tracking Service data for
2003–2009. ***** 25% of this 7.76% was then allocated for RH,
based on NIDI estimates.
Reconstruction relief and rehabilitation (73010) 1.94
*Direct RH categories based on categories defined in the 1994 ICPD and subsequently used in van Dalen H, Reuser M, Assessing size and
structure of worldwide funds for population and AIDS activities, UNFPA/UNAIDS/NIDI Resource Flows Project, 2005, www.resourceflows.org/
index.php?module=uploads&func=download&fileId=99 (accessed 17 March 2015).
**Reproductive health care includes promotion of reproductive health; prenatal and postnatal care including delivery; prevention and treatment
of infertility; prevention and management of consequences of abortion; safe motherhood activities.
***de Bruijn & Horstman.52
****Source: WHO (2007). World Health Statistics. Geneva: World Health Organization.
*****Source: UNOCHA (2012). The Global Humanitarian Aid Database: Financial Tracking System. http://fts.unocha.org/ (accessed 17 March 2015).
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statistically significant (P < 0.01) associated with our out-
come, until we reached a model where every variable
included was significantly associated. Our final multivariate
models are adjusted for categories of HIV prevalence rate,
GDP per capita, government effectiveness and control of
corruption. We present here the association coefficients
reflecting the unit decrease/increase in the continuous RH
ODA outcomes according to conflict status per disburse-
ment.
The pattern of reproductive health ODA distribution
and reproductive health needs to the individual conflict-
affected countries were explored descriptively through the
use of scatter plots for specific reproductive health indica-
tors (indicator data taken from the sources in Table S1)
and the average annual (2002–2011) per capita ODA
specifically for their most closely related CRS purpose code
activity (see Box 2 for the purpose codes): HIV/AIDS
prevalence and HIV/AIDS and STD control and social mit-
igation of HIV/AIDS (purpose codes 16064 and 13040
combined), maternal mortality rates and reproductive
health care ODA (purpose code 13020); and total fertility
rate and family planning ODA (purpose code 13030).
We also ran three multivariate linear regression models
further to examine the association between reproductive
ODA disbursements and reproductive health needs among
all the conflict-affected countries combined while adjusting
for potential confounders. The first model examined the
association of a dependent continuous variable of mean
2002–2011 per capita US$ ODA per disbursement for HIV/
AIDS (purpose codes 13040 and 16064) and HIV preva-
lence, with HIV prevalence data categorised into equal dis-
tribution quartiles to aid interpretation. The second model
examined the association of mean 2002–2011 per capita US
$ ODA per disbursement for reproductive health care (pur-
pose code 13020) with maternal mortality, with maternal
mortality ratios categorised equally into tertiles. The third
model examined the association of mean 2002–2011 per
capita US$ ODA per disbursement for family planning
(purpose code 13030) with total fertility rate which was
again categorised equally into tertiles. We used stepwise
regression for each of these models, beginning first with
the full range of possible confounders noted above and
eliminating those that were not statistically significantly
associated with the outcome of interest (P < 0.01). The
confounders controlled for in each final multivariate model
are listed in Table 3.
Results
The distribution of ODA for reproductive health to the 18
conflict-affected countries is shown in Table 1. ODA for
reproductive health to the 18 conflict-affected countries
increased by 298%, from US$ 303.5 million in 2002 to US$
1,208.9 million in 2011 (compared with a 178% increase in
all ODA), with an annual average of US$ 747.0 million dis-
bursed to conflict-affected countries for reproductive health
activities during the study period. This equates to US$ 1.93
in reproductive health ODA per person per year to con-
flict-affected countries, 3% of all ODA during the study
period (annual average all ODA of US$ 24,568.5 million;
US$ 63.2 per capita; see Supporting Information Table S2).
The conflict-affected countries receiving the highest annual
average per capita reproductive health ODA were Uganda
(US$ 8.1), Timor-Leste (US$ 6.7) and Liberia (US$ 5.4);
and the countries receiving the lowest were Colombia (US$
0.2), Myanmar (US$ 0.4), and Sri Lanka (US$ 0.7).
The distribution of reproductive health ODA disbursed
to the 15 of the 18 conflict-affected countries which were
classified as ‘least developed countries’ was compared with
equivalent non-conflict-affected least developed countries
(Table 1).53 The data show that the annual average per
capita reproductive health ODA disbursed to non-conflict-
affected least developed counties (US$ 3.60) was 57%
higher than to least developed conflict-affected-countries
(US$ 2.30). In addition, 4.4% of all ODA disbursed to con-
flict-affected least developed countries was for reproductive
health activities, compared with 7.0% in non-conflict-
affected least developed countries.
The relation between countries being conflict-affected
and levels of reproductive health ODA disbursements was
investigated through the multivariate regression analysis
(Table 2). After adjustment for the potential confounders,
our findings suggest that being a conflict-affected least
developed country (compared with a non-conflict-affected
least developed country) is associated with receiving lower
per capita all reproductive health ODA per disbursement
(B = 0.00021; P = 0.056), lower per capita direct repro-
ductive health ODA per disbursement (B = 0.00030;
P = 0.024), lower HIV/AIDS-specific ODA per disburse-
ment (B = 0.00002; P = 0.967), but increased reproduc-
tive health care ODA per disbursement (B = 0.00205;
P = 0.05) and increased family planning ODA per dis-
bursement (B = 0.00119; P = 0.005).
The activities to which the reproductive health-related
ODA to conflict-affected countries was disbursed are given
in Box 2 (and detailed in Supporting Information
Table S3). Of the US$ 747 million disbursed on average
per year to conflict-affected countries for reproductive
health activities, two-thirds (66.2%) was for direct repro-
ductive health activities. The data show that an annual
average of US$ 322.69 million was disbursed for HIV/AIDS
activities (purpose codes for ‘HIV/AIDS and STD control’
and ‘Social mitigation of HIV/AIDS’). This represents
43.2% of the US$ 747 million in ODA average annual
disbursements for reproductive health (direct and indirect).
The average annual ODA disbursed for direct reproductive
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health activities, excluding HIV/AIDS activities, was $172.2
million, or 23.0% of the average annual ODA disbursed for
all reproductive health activities. The most significant dis-
bursements for the non-HIV reproductive health activities
were for reproductive health care (purpose code 13020)
(13.3%) and basic health care (10.5%) (purpose code
12220). Over half (56.3%) of the 298% increase in total
reproductive health disbursements during the study period
was due to the substantial increase in HIV/AIDS funding.
Reproductive health care activities accounted for 19.3% of
the 298% increase.
The dominance of HIV/AIDS funding as a proportion of
total reproductive health funding (direct and indirect) is
greater in the conflict-affected least developed countries
(53.2%) than in the non-conflict-affected least developed
countries (39.5%) despite the latter generally appearing to
have higher prevalences of HIV/AIDS and lower levels of
other types of reproductive health needs (Supporting Infor-
mation Tables S1 and S4).
These relationships between mean per capita reproduc-
tive health ODA disbursements (2002–2011) and repro-
ductive health needs are shown in the regression analyses
in Table 3. The findings suggest a general lack of
response of reproductive health ODA to reproductive
health needs, and in some categories of need for conflict-
affected countries. Indeed, countries with a high maternal
mortality ratio category of >1000 had a negative associa-
tion (B = 0.01701; P < 0.001) with reproductive health
care ODA (purpose code 13020) when compared with
those with a lower maternal mortality ratio category of
≤650. Similarly, countries with a higher HIV prevalence
of >10% had a negative association (B = 0.00100;
P = 0.001) with HIV/AIDS ODA (purpose codes 16064
and 13040 combined) when compared with those with a
lower prevalence category of <1.0%. However, ODA for
family planning appeared to be more responsive to need
(B = 0.01839; P = 0.03), with a higher total fertility rate
category (>6.0) associated with higher family planning
ODA (purpose code 13030) compared with a lower fertil-
ity rate category of ≤4.50. The unadjusted patterns
between per capita reproductive health ODA disburse-
ments and reproductive health needs for individual coun-
tries are given in the scatter plots in Supporting
Information Figure S1. These show that a number of
countries (e.g. Chad, Somalia, Central Africa Republic,
and the Democratic Republic of Congo) with high repro-
ductive health needs receive considerably less per capita
ODA than other conflict-affected countries with lower
reproductive health needs.
The disbursement patterns by donor are provided in
Supporting Information Table S5. The donors disbursing
the highest amount of absolute bilateral reproductive
health-related ODA were the USA (with increases in US
ODA in 2008 and 2009 largely accounting for the substan-
Table 2. Regression analyses on association between countries being conflict-affected and mean per capita RH ODA (2002–2011)
RH ODA category model Bivariate models Multivariate models*
Coefficient 95% CI P Coefficient 95% CI P
All RH ODA model
Non-conflict LDC Ref Ref
Conflict-affected LDC 0.0018626 0.00249; 0.00123 <0.001 0.00021 0.00043; 0.0000005 0.056
Direct RH ODA model
Non-conflict LDC Ref Ref
Conflict-affected LDC 0.0021908 0.00296; 0.00142 <0.001 0.00030 0.00056; 0.00004 0.024
HIV/AIDS ODA model
Non-conflict LDC Ref Ref
Conflict-affected LDC 0.0019187 0.00299; 0.00084 <0.001 0.0000199 0.00095; 0.000909 0.967
Reproductive health care ODA model**
Non-conflict LDC Ref Ref
Conflict-affected LDC 0.0011517 0.00167; 0.003972 0.423 0.00205 0.00617; 0.00349 0.005
Family planning ODA model
Non-conflict LDC Ref Ref
Conflict-affected LDC 0.0003792 0.0003; 0.001062 0.276 0.00119 0.00041; 0.00200 0.003
LDC, least developed country; ODA, official development assistance; Ref; reference category.
*Each of the five multivariate regression models run separately after stepwise elimination of non-significant variables. All final models adjusted for
HIV prevalence rate, GDP per capita, government effectiveness and control of corruption.
**Reproductive health care includes reproductive health promotion, prenatal/postnatal/delivery care, safe motherhood, fertility treatment, abortion
related care (see Box 2).
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tial increase in all reproductive health ODA to the conflict-
affected countries – albeit mostly for HIV/AIDS), Japan,
Germany and the UK. The bilateral donors disbursing the
highest proportion of their ODA to reproductive health
were Ireland (9.3%), Denmark (5.1%) and Iceland (4.2%).
Newer bilateral donors such as Czech Republic, South
Korea and the United Arab Emirates reported ODA for
reproductive health in CRS, but not in very significant
amounts. Multilateral donors disbursing the highest
amount of absolute reproductive health-related ODA were
the World Bank and the European Union.
Discussion
Main findings
There was a substantial increase (298%) in ODA funding
for reproductive health activities to the 18 conflict-affected
countries between 2002 and 2011. This includes recent
increases in ODA for previously neglected topics such as
family planning in 2008 and 2009. Similarly, ODA for the
reproductive health care category purpose code increased
in 2008, 2009, 2010 and 2011, which addresses critical
interventions such as maternal health care. This perhaps
reflects increasing advocacy and engagement in reproduc-
tive health humanitarian programming.13,54–56 However,
the majority of the increase in overall reproductive health
funding during the review period is explained by increased
ODA for HIV/AIDS activities.
This study also shows that non-conflict-affected least-
developed countries received 57% more reproductive health
ODA per capita compared with the conflict-affected least-
developed countries during the decade reviewed, support-
ing findings from other studies.57 After adjustment for
potential confounding factors, the disparity largely
remained. The new findings also show considerable aid dis-
parity between conflict-affected countries, with certain
countries with extremely high reproductive health needs
(such as those with high maternal mortality and other
health needs as shown in Table S1) receiving considerably
fewer funds compared with other countries with lower
reproductive health needs. The regression analysis provides
additional evidence of this disparity between reproductive
health needs and ODA among conflict-affected countries,
with the exception of family planning. Potential explana-
tions for the disparity in reproductive health funding
towards conflict-affected countries include concerns over
security, absorptive capacity and governance in the recipi-
ent countries, and varying media and policy attention.
The findings suggest there remains a substantial shortfall
in ODA to meet reproductive health needs, which are esti-
mated to be $70 billion annually in 2015 globally.58,59
Resource requirements for sustaining the current use of
Table 3. Regression analyses on association of reproductive health ODA with reproductive health needs among conflict-affected countries
RH ODA category model* Bivariate Multivariate**
Coefficient 95% CI P Coefficient 95% CI P
Model 1: HIV/AIDS ODA
≤1.0% prevalence Ref Ref
1.01–2.0% prevalence 0.00070 0.0012; 0.00261 0.469 0.003150 0.0000009; 0.006309 0.051
2.01–10.0% prevalence 0.00184 0.00053; 0.00315 0.006 0.0000653 0.002126; 0.00226 0.953
>10.0% prevalence 0.00484 0.00195; 0.00773 0.001 0.00100 0.01576; 0.00413 0.001
Model 2: Reproductive health care ODA***
MMR ≤650 Ref Ref
MMR 651–1000 0.00306 0.00481; 0.0013 0.001 0.01911 0.0133; 0.02491 <0.001
MMR >1000 0.00081 0.00221; 0.00058 0.252 0.01701 0.02195; 0.01208 <0.001
Model 3: Family planning ODA
TFR ≤4.50 Ref Ref
TFR 4.51–5.9 0.00018 0.01098; 01062 0.974 0.01027 0.02286; 0.00232 0.110
TFR >6.0 0.00477 0.00059; 0.00895 0.025 0.01839 0.00138; 0.03540 0.034
MMR, maternal mortality ratio; ODA, official development assistance; Ref, Reference category; TFR; total fertility rate.
*Mean 2002–2011 per capita US$ ODA for: HIV/AIDS only ODA (model 1); RH care only ODA (model 2); and family planning ODA (model 3).
**Each of the three multivariate regression models run separately after stepwise elimination. Final Model 1 adjusted for maternal mortality ratio,
fertility rate and government effectiveness. Final Model 2 adjusted for HIV prevalence, fertility rate, GDP per capita and government effectiveness.
Final Model 3 adjusted for HIV prevalence, maternal mortality ration, GDP per capita and government effectiveness.
***reproductive health care includes reproductive health promotion, prenatal/postnatal/delivery care, safe motherhood, fertility treatment,
abortion related care (see Box 2).
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contraception by 260 million women in the 69 poorest
countries is estimated to be approximately US$ 10 billion
over 8 years from 2012 to 2020.60 However, there are no
current reliable estimates of reproductive health needs and
related funding for reproductive health activities in con-
flict-affected countries. Also, estimates of resource require-
ments for reproductive health ODA in resource-poor
countries are thought to be misleadingly low, as they do
not take into account crucial service delivery costs, which
are likely to be higher in conflict-affected countries because
of logistical challenges.61
Strengths
This study provides evidence of long-term trends in
reproductive health ODA distribution for conflict-affected
countries using the CRS reporting system. Analysis pre-
sented in this study shows that there is considerable
disparity in the disbursement of reproductive health ODA
between conflict-affected and non-conflict-affected coun-
tries (as well as between conflict-affected countries). The
findings are useful in understanding how responsive aid is
to levels of reproductive health needs in conflict-affected
countries.
Limitations
There are a number of administrative limitations with the
CRS reporting system. Our aid data review period (2002–
2011) does not capture recent significant donor commit-
ments for reproductive health such as the Global Strategy
for Women’s and Children’s Health to mobilise US$ 40
billion to save the lives of 16 billion women and children
over 5 years, and other significant donor pledges for family
planning including for post-conflict countries.60,62–64 How-
ever, complete disbursement data relating to these pledges
will not yet show in CRS.
The CRS database does not include a purpose code for
gender-based violence (GBV). Aid activities related to gen-
der-based violence (GBV) are often also included in larger
projects under human rights activities, protection, elections
and post-conflict peace-building activities. It is not possible
to apportion a percentage for GBV from these more gen-
eral and large-scale projects. A separate purpose code for
GBV would enhance significantly understanding of patterns
of aid allocations for this crucial issue.23
For the CRS purpose code on ‘STD control, including
HIV/AIDS’, it not possible to disaggregate funding for HIV
from other STDs and so we cannot examine funding for
other STDs. We are also not able to disaggregate funding
for the ‘Reproductive Health Care’ purpose code (for
example, for delivery care or comprehensive abortion care).
This study was limited to estimating donor aid disburse-
ments at national levels, so it is not possible to know what
proportion of aid disbursement is spent on the ground and
with which populations. We could not therefore determine
how ODA was disbursed to conflict-affected regions and
populations within each of the conflict-affected countries.
This is especially relevant in conflict-affected countries as
conflicts tend to occur in geographically distinct areas (e.g.
Sudan, Sri Lanka and northern Uganda). A related limita-
tion is that South Sudan has not yet been included as a
separate country by CRS after becoming an independent
state in 2011, and so aid disbursements to South Sudan are
included under Sudan.
It is difficult to estimate what percentage of a country’s
population is affected by conflict and how that may have
changed over the study period. In addition, as rigorous and
representative reproductive health data are insufficiently
recorded with conflict-affected populations, we have been
forced to use national-level data for our models. There is a
critical need for more reproductive health data specifically
from conflict-affected populations. There is also a need for
in-depth, country- and local region-specific research to
investigate the ground-level disbursement of reproductive
health ODA.
Countries affected by natural disasters and/or undergoing
political conflict, such as Syria, or transition, such as other
Arab Spring countries, have also been excluded from this
study in order to maintain a distinctive focus on countries
affected by major armed conflict during the study period
from 2002 to 2011. Several reports have described the chal-
lenges of reproductive health in disaster-affected countries
and the Arab Spring countries.65,66 Further studies are nec-
essary to track ODA for these groups of countries.
Aid from other bilateral donors such as the BRICS (Bra-
zil, Russia, India, China, and South Africa) and Turkey
(which provides significant amounts of humanitarian assis-
tance), is not currently included in CRS. Studies suggest
that the aid flows of such donors have nearly quadrupled,
from an estimated 8.1% of total development assistance in
2000 to 30.7% of the total in 2009.67,68 Aid from private,
philanthropic and non-governmental organisations is also
excluded from our study, as most of these organisations do
not currently report their aid disbursements to CRS. The
Bill and Melinda Gates Foundation has been reporting
some of its funding to CRS since 2009 under a private
grants category. This has not been analysed in this study as
it does not constitute ODA and is not comprehensive or
standardised enough to offer sufficiently reliable data on
disbursements to conflict-affected countries.69 Contribu-
tions from these emerging and large private donors have
become an increasingly relevant source of financing in
recent years, with some major private donors rivalling
many traditional multilateral and bilateral donors in terms
of the scale of their funding. Global Humanitarian Assis-
tance provides analysis of funding from private organisa-
tions but it is not possible to disaggregate their data into
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sectors such as reproductive health.68 Increased aid report-
ing by private organisations to a centralised data repository
such as CRS would significantly enhance the efficiency and
effectiveness of this important sector.39
Finally, although we used multivariate regression analysis
to adjust for potential confounders when examining the
relationships between conflict status and reproductive
health ODA and also between reproductive health needs
and reproductive health ODA, it is probable that there are
unobserved confounders which may have a significant
influence on these relationships.
Interpretation
The findings suggest reproductive health aid disparities to
and between conflict-affected countries. In-depth, country-
specific research is required to investigate the supply and
demand characteristics of reproductive health ODA. The
findings from such research can help inform advocacy ini-
tiatives to improve donor accountability and co-ordination,
and ensure more equitable distribution of ODA to meet
the reproductive health needs of populations affected by
conflict.
Conclusion
The evidence presented in this study tracking 10 years of
reproductive health aid disbursements suggests that
although there is some room for optimism from the increase
in ODA for reproductive health for conflict-affected coun-
tries from 2002 to 2011, the bulk of the increased funding is
attributable to HIV/AIDS activities, and other reproductive
health activities have not benefited from such increases.
Importantly, there is also a disparity in the disbursement of
reproductive health ODA between conflict-affected and
non-conflict-affected countries (as well as between conflict-
affected countries). The funding inequities presented in this
study remain substantial obstacles for conflict-affected
countries which remain highly dependent on ODA and are
the furthest away from achieving the MDGs.70,71
Disclosure of interests
None declared. Completed disclosure of interests form
available to view online as supporting information.
Contribution to authorship
PP conceptualised the paper and developed the study
methodology, with contributions from BR, MD and MT.
MD and BR primarily conducted the data analysis, which
was reviewed by AM. PP wrote the first draft of the paper
with contributions from BR. MT, SG, LE contributed to
the writing process. All authors reviewed and approved the
final text.
Details of ethics approval
No ethical approval was required for this study as all data
used for the study is available in the public domain.
Funding
This study was funded by the Bureau for Population, Refu-
gee and Migration and the MacArthur Foundation,
through the Women’s Refugee Commission.
Acknowledgements
We would like to thank Louise-Lee Jones and Catrin
Schulte-Hillen.
Supporting Information
Additional Supporting Information may be found in the
online version of this article:
Figure S1. Maternal mortality and reproductive health
care ODA
Table S1. Key reproductive health and socio-economic
indicators for conflict- and non-conflict-affected least
developed countries
Table S2. All ODA (US $ million) to conflict-affected
countries, by year
Table S3. Distribution of reproductive health ODA
2002-2011 to conflict-affected countries, by activity (US $
million)
Table S4. Comparison of HIV only disbursements versus
disbursements for all other direct and indirect reproductive
health activities, by conflict status
Table S5. Donor disbursement of reproductive health
ODA for sampled conflict-affected countries (US $
million)&
References
1 UNFPA. Improving reproductive health. [www.unfpa.org/rh/
index.htm]. Accessed 15 November 2013.
2 Women Deliver post-2015. Lancet 2013;381:1687.
3 Black BO, Bouanchaud PA, Bignall JK, Simpson E, Gupta M.
Reproductive health during conflict. Obstet Gynaecol 2014;16:153–
60.
4 Min M. Reproductive health-care provision in emergencies:
preventing needless suffering. Forced Migr Rev 2009;32:68–9.
5 WHO/UNICEF/UNFPA/The World Bank. Trends in maternal mortality:
1990 to 2010. 2012.
6 O’Hare BA, Southall DP. First do no harm: the impact of recent
armed conflict on maternal and child health in Sub-Saharan Africa. J
R Soc Med 2007;100:564–70.
7 Coghlan B, Brennan RJ, Ngoy P, Dofara D, Otto B, Clements M,
et al. Mortality in the Democratic Republic of Congo: a nationwide
survey. Lancet 2006;367:44–51.
8 Singhrao R, Huchko M, Yamey G. Reproductive and maternal health
in the post-2015 era: cervical cancer must be a priority. PLoS Med
2013;10:e1001499.
1702 ª 2016 The Authors. BJOG An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd on behalf of
Royal College of Obstetricians and Gynaecologists.
Patel et al.
9 UNFPA. Global Review of Challenges and Good Practices in Support
of Displaced Women in Conflict and Post-Conflict Situations.
Hammamet, Tunisia: 21–24 June 2007.
10 UN. Women, peace and security. [www.peacewomen.org/].
Accessed 16 December 2015.
11 The Lancet. Ending sexual violence in conflict and beyond. Lancet
2014;pii: S0140-6736(14)60972-7.
12 IAWG. Inter-agency field manual on reproductive health in
humanitarian settings. 2010.
13 Sphere Project. Humanitarian charter and minimum standards in
humanitarian response. 2011.
14 Minimum initial services package for reproductive health 2008.
[www.iawg.net/resources/MISP cheat sheet 12 17 09_FINAL.pdf].
Accessed 16 December 2015.
15 IASC. Guidelines for Addressing HIV in Humanitarian Settings.
Geneva: Inter Agency Standing Committee, 2010.
16 UNFPA. Sexual and reproductive health for all: reducing poverty,
advancing development and protecting human rights. 2010.
17 Canning D, Schultz TP. The economic consequences of reproductive
health and family planning. Lancet 2012;380:165–71.
18 Jacobstein R, Curtis C, Spieler J, Radloff S. Meeting the need for
modern contraception: effective solutions to a pressing global
challenge. Int J Gynaecol Obstet 2013;121 (Suppl 1):S9–15.
19 Ahmed S, Li Q, Liu L, Tsui AO. Maternal deaths averted by
contraceptive use: an analysis of 172 countries. Lancet
2012;380:111–25.
20 McGinn T, Austin J, Anfinson K, Amsalu R, Casey SE, Fadulalmula
SI, et al. Family planning in conflict: results of cross-sectional
baseline surveys in three African countries. Confl Health 2011;5:11.
21 Casey SE, McNab SE, Tanton C, Odong J, Testa AC, Lee-Jones L.
Availability of long-acting and permanent family-planning methods
leads to increase in use in conflict-affected northern Uganda:
evidence from cross-sectional baseline and endline cluster surveys.
Glob Public Health 2013;8:284–97.
22 Millennium development goals: goal 5: improve maternal health
(Internet). [www.un.org/millenniumgoals/maternal.shtml]. Accessed
7 November 2013
23 Patel P, Roberts B, Guy S, Lee-Jones L, Conteh L. Tracking official
development assistance for reproductive health in conflict-affected
countries. PLoS Med 2009;6:e1000090.
24 UK Parliament. Working effectively in fragile and conflict-affected
states: DRC, Rwanda and Burundi. 2011.
25 Hulton L, Murray S, Thomas D. The Evidence Towards MDG 5: A
Working Paper. London: Options, 2010.
26 WHO/UNFPA. Sexual and reproductive health during protracted
crises and recovery. 2011.
27 Patel P, Roberts B. Aid for reproductive health: progress and
challenges. Lancet 2013;381:1701–2.
28 Spiegel PB, Cornier N, Schilperoord M. Funding for reproductive
health in conflict and post-conflict countries: a familiar story of
inequity and insufficient data. PLoS Med 2009;6:e1000093.
29 Esser DE, Bench KK. Does global health funding respond to
recipients’ needs? comparing public and private donors’ allocations
in 2005–2007. World Dev 2011;39:1271–80.
30 UN. Report of the International Conference on Population and
Development, Cairo, 5–13 September 1994. New York: United
Nations, 1995.
31 WHO. Reproductive health. [www.who.int/topics/reproductive_
health/en/]. Accessed 17 March 2015.
32 OECD. Reporting directives for the creditor reporting system. 2007.
33 OECD. Purpose codes: sector classification. [www.oecd.org/dac/stats/
purposecodessectorclassification.htm]. Accessed 5 December 2013.
34 Uppsala University. UCPD conflict encyclopedia. [www.ucdp.uu.se/
gpdatabase/search.php]. Accessed 17 March 2015
35 World Bank. Engaging with Fragile States: an IEG review of World
Bank support to low-income countries under stress. 2006.
36 Wallensteen P, Sollenberg M. Armed conflict 1989–2000. J Peace
Res 2001;38:629–44.
37 Brown G, Langer A, Stewart F. A Typology of Post-conflict
Environments. London: Centre for Research on Inequality, Human
Security and Ethnicity, 2011.
38 Collier P, Hoeffler A, S€oderbom M. Post-conflict risks. J Peace Res
2006;45:461–78.
39 Patel P, Roberts B, Conteh L, Guy S, Lee-Jones L. A review of global
mechanisms for tracking official development assistance for health
in countries affected by armed conflict. Health Policy 2011;100:116–
24.
40 Hsu J, Berman P, Mills A. Reproductive health priorities: evidence
from a resource tracking analysis of official development assistance
in 2009 and 2010. Lancet 2013;381:1772–82.
41 Ravishankar N, Gubbins P, Cooley RJ, Leach-Kemon K, Michaud
CM, Jamison DT, et al. Financing of global health: tracking
development assistance for health from 1990 to 2007. Lancet
2009;373:2113–24.
42 Powell-Jackson T, Borghi J, Mueller DH, Patouillard E, Mills A.
Countdown to 2015: tracking donor assistance to maternal,
newborn, and child health. Lancet 2006;368:1077–87.
43 Pitt C, Greco G, Powell-Jackson T, Mills A. Countdown to 2015:
assessment of official development assistance to maternal, newborn,
and child health, 2003–08. Lancet 2010;376:1485–96.
44 Greco G, Powell-Jackson T, Borghi J, Mills A. Countdown to 2015:
assessment of donor assistance to maternal, newborn, and child
health between 2003 and 2006. Lancet 2008;371:1268–75.
45 Tol WA, Barbui C, Galappatti A, Silove D, Betancourt TS, Souza R,
et al. Mental health and psychosocial support in humanitarian
settings: linking practice and research. Lancet 2011;378:1581–91.
46 Warsame A, Patel P, Checchi F. Patterns of funding allocation for
tuberculosis control in fragile states. Int J Tuberc Lung Dis
2014;18:61–6.
47 OECD. Technical Guide to terms and data in the Creditor Reporting
System (CRS) Aid Activities database. [www.oecd.org/dac/stats/
crsguide.htm]. Accessed 5 December 2013.
48 Aidinfo. Using OECD DAC aid statistics. [www.aidinfo.org/wp-
content/uploads/2010/09/Using-OECD-DAC-aid-statistics1.pdf].
Accessed 17 March 2015.
49 Grepin KA, Leach-Kemon K, Schneider M, Sridhar D. How to do (or
not to do). . . Tracking data on development assistance for health.
Health Policy Plan 2012;27:527–34.
50 Development initiatives. Global humanitarian assistance: use case on
humanitarian aid information. 2010.
51 Van Dalen H, Reuser M. Assessing Size and Structure of Worldwide
Funds for Population and AIDS Activities. The Hague: NIDI, 2005.
52 de Bruijn B, Horstman R. Population and AIDS Activities in Health
Sector-Wide Approaches: A Method for Estimating Category
Expenses in Pooled Funds. The Hague: NIDI; 2005.
53 OECD. The DAC list of ODA recipients 2012. [www.oecd.org/dac/
stats/49483614.pdf]. Accessed 17 March 2015.
54 IAWG. Inter-agency Working Group on reproductive health in crises.
[http://iawg.net/]. Accessed 11 December 2013.
55 IASC. Health cluster guide: a practical guide for country-level Health
Cluster Lead Agencies, Coordinators and Partners. 2009. Report
No.: WHO/HAC/MAN/2009.7.
56 IASC. Guidelines for addressing HIV in humanitarian settings. 2010.
1703ª 2016 The Authors. BJOG An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd on behalf of
Royal College of Obstetricians and Gynaecologists.
Aid for reproductive health and conflict
57 Dollar D, Levin V. The Forgotten States: aid volumes and volatility in
difficult partnership countries (1992–2002): summary paper
prepared for DAC learning and advisory process on difficult
partnerships. 2005.
58 UNFPA. Financing the ICPD programme of action: fifteen years later.
59 Singh S, Darroch JE, Ashford LS, Vlassoff M. Adding It Up: The
Costs and Benefits of Investing in Family Planning and Maternal and
Newborn Health. New York: Guttmacher Institute and the UNFPA,
2009.
60 Bill and Melinda Gates Foundation. Landmark summit puts women
at heart of global health agenda. 2012.
61 Schaferhoff M, Schrade C, Yamey G. Financing maternal and child
health—what are the limitations in estimating donor flows and
resource needs? PLoS Med 2010;7:e1000305.
62 The Global Campaign. Putting the Global Strategy for Women’s and
Children’s Health into action. New York: Ministry of Foreign Affairs,
Norway and the United Nations, 2010.
63 London Summit on Family planning. Summaries of commitments.
[www.gov.uk/government/uploads/system/uploads/attachment_data/
file/67328/london-summit-family-planning-commitments.pdf] Accessed
16 December 2015.
64 UNFPA. New initiative to boost family planning services for youth,
vulnerable groups, countries in transition. 2013 [www.unfpa.org/
public/home/news/pid/14232 - sthash.H1hAuRI6.dpuf]. Accessed 29
May 2013.
65 Devi S. Women’s health challenges in post-revolutionary Egypt.
Lancet 2013;381:1705–6.
66 Swatzyna RJ, Pillai VK. The effects of disaster on women’s
reproductive health in developing countries. Glob J Health Sci
2013;5:106–13.
67 Greenhill RP, Rogerson A. The age of choice: developing countries
in the new aid landscape. 2013. Overseas Development Institute
Report No Working Paper 364.
68 Stoianova V. Private funding for humanitarian assistance: filling the
gap? Development Initiatives; 2013.
69 Sridhar D, Batniji R. Misfinancing global health: a case for
transparency in disbursements and decision making. Lancet 2008;
372:1185–91.
70 OECD. Fragile States 2013: resource flows and trends in a shifting
world. 2013.
71 World Bank. Conflict, Security and Development. Washington, DC:
World Bank; 2011.
1704 ª 2016 The Authors. BJOG An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd on behalf of
Royal College of Obstetricians and Gynaecologists.
Patel et al.
